A Multicenter Randomized Controlled Pilot Trial Testing the Efficacy and Safety of Pterygopalatine Fossa Puncture Using One Acupuncture Needle for Moderate-to-Severe Persistent Allergic Rhinitis
Table 3
Demographic data for the participants in each group.
Intervention (n = 48)
Verum acupuncture (n = 48)
value
Statistic
Age (years)
39.03 ± 10.25
44.73 ± 9.72
0.456
t-test
Gender (male/female)
15/33
20/28
0.417
Chi-squared test
Disease course (months)
52.47 ± 49.12
58.12 ± 64.47
0.846
Mann–Whitney test
Symptomatic days in the last month
25.87 ± 5.79
23.61 ± 8.34
0.403
Mann–Whitney test
TNSS
11.47 ± 2.35
9.92 ± 2.67
0.278
Multivariate ANOVA
TNNSS
2.81 ± 1.12
2.72 ± 1.51
0.761
Multivariate ANOVA
RQLQ
80.11 ± 18.12
74.82 ± 24.93
0.801
Multivariate ANOVA
Activities
1214 ± 3.32
12.51 ± 5.91
0.683
Sleep
6.73 ± 4.31
7.83 ± 4.62
0.273
Nonnasal/eye
15.81 ± 6.71
16.63 ± 7.82
0.671
Practical problems
13.93 ± 3.45
13.08 ± 4.21
0.242
Nasal problems
13.91 ± 2.63
13.72 ± 3.63
0.758
Eye symptoms
9.37 ± 6.54
7.51 ± 5.07
0.216
Emotional function
9.33 ± 5.31
7.57 ± 4.87
0.076
Physical sign (score)
2.23 ± 0.62
2.24 ± 0.61
0.601
Mann–Whitney test
ANOVA, analysis of variance; TNSS, total nasal symptom score; TNNSS, total nonnasal symptom score; RQLQ, Rhinitis Quality of Life Questionnaire.
